Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials
- PMID: 20726007
- DOI: 10.1002/ardp.200900319
Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials
Abstract
Curcumin (diferuloylmethane), a derivative of turmeric is one of the most commonly used and highly researched phytochemicals. Abundant sources provide interesting insights into the multiple mechanisms by which curcumin may mediate chemotherapy and chemopreventive effects on cancer. The pleiotropic role of this dietary compound includes the inhibition of several cell signaling pathways at multiple levels, such as transcription factors (NF-κB and AP-1), enzymes (COX-2, MMPs), cell cycle arrest (cyclin D1), proliferation (EGFR and Akt), survival pathways (β-catenin and adhesion molecules), and TNF. Curcumin up-regulates caspase family proteins and down-regulates anti-apoptotic genes (Bcl-2 and Bcl-X(L)). In addition, cDNA microarrays analysis adds a new dimension for molecular responses of cancer cells to curcumin at the genomic level. Although, curcumin's poor absorption and low systemic bioavailability limits the access of adequate concentrations for pharmacological effects in certain tissues, active levels in the gastrointestinal tract have been found in animal and human pharmacokinetic studies. Currently, sufficient data has been shown to advocate phase II and phase III clinical trials of curcumin for a variety of cancer conditions including multiple myeloma, pancreatic, and colon cancer.
Similar articles
-
Curcumin: the story so far.Eur J Cancer. 2005 Sep;41(13):1955-68. doi: 10.1016/j.ejca.2005.05.009. Eur J Cancer. 2005. PMID: 16081279 Review.
-
Curcumin for chemoprevention of colon cancer.Cancer Lett. 2007 Oct 8;255(2):170-81. doi: 10.1016/j.canlet.2007.03.005. Epub 2007 Apr 19. Cancer Lett. 2007. PMID: 17448598
-
Curcumin and cancer: an "old-age" disease with an "age-old" solution.Cancer Lett. 2008 Aug 18;267(1):133-64. doi: 10.1016/j.canlet.2008.03.025. Epub 2008 May 6. Cancer Lett. 2008. PMID: 18462866 Review.
-
Curcumin in various cancers.Biofactors. 2013 Jan-Feb;39(1):56-68. doi: 10.1002/biof.1068. Epub 2013 Jan 10. Biofactors. 2013. PMID: 23303705 Review.
-
New mechanisms and therapeutic potential of curcumin for colorectal cancer.Mol Nutr Food Res. 2008 Sep;52(9):1040-61. doi: 10.1002/mnfr.200700280. Mol Nutr Food Res. 2008. PMID: 18655004 Review.
Cited by
-
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.Br J Cancer. 2024 Mar;130(5):703-715. doi: 10.1038/s41416-023-02502-9. Epub 2023 Nov 27. Br J Cancer. 2024. PMID: 38012383 Free PMC article. Review.
-
Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective.Antioxidants (Basel). 2023 Sep 6;12(9):1725. doi: 10.3390/antiox12091725. Antioxidants (Basel). 2023. PMID: 37760028 Free PMC article. Review.
-
Lysosomes, curcumin, and anti-tumor effects: how are they linked?Front Pharmacol. 2023 Jul 7;14:1220983. doi: 10.3389/fphar.2023.1220983. eCollection 2023. Front Pharmacol. 2023. PMID: 37484013 Free PMC article. Review.
-
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future.Pharmaceutics. 2023 May 29;15(6):1612. doi: 10.3390/pharmaceutics15061612. Pharmaceutics. 2023. PMID: 37376060 Free PMC article. Review.
-
Real-time monitoring of NIR-triggered drug release from phase-changeable nanodroplets by photoacoustic/ultrasound imaging.Photoacoustics. 2023 Mar 12;30:100474. doi: 10.1016/j.pacs.2023.100474. eCollection 2023 Apr. Photoacoustics. 2023. PMID: 37025112 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
